Insider · CIK 0001291804
George Jean
Reports to the SEC for 10 companies · WALTHAM, MA
Transactions
50
Companies
10
Filings
8
CIK
0001291804
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2024-02-14 | Cyteir Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2024-02-14 | Cyteir Therapeutics, Inc.M Exercise/Conversion | +$23.9K |
| 2023-02-03 | Cyteir Therapeutics, Inc.Stock Option (Right to Buy)A Award | — |
| 2022-02-22 | Cyteir Therapeutics, Inc.Stock Option (Right to Buy)A Award | — |
| 2021-06-22 | Cyteir Therapeutics, Inc.Series B Convertible Preferred StockC Conversion | — |
| 2021-06-22 | Cyteir Therapeutics, Inc.Series C Convertible Preferred StockC Conversion | — |
| 2021-06-22 | Cyteir Therapeutics, Inc.C Conversion | — |
| 2021-06-11 | Calithera Biosciences, Inc.Stock Option (Right to Buy)A Award | — |
| 2020-06-09 | Calithera Biosciences, Inc.Stock Option (Right to Buy)A Award | — |
| 2020-01-22 | ACCELERON PHARMA INCA Award | — |
| 2020-01-22 | ACCELERON PHARMA INCOption to Purchase Common StockA Award | — |
| 2019-06-28 | ACCELERON PHARMA INCS Sale | −$486K |
| 2019-06-26 | ACCELERON PHARMA INCJ Other | — |
| 2019-06-26 | ACCELERON PHARMA INCS Sale | −$1.01M |
| 2019-06-26 | ACCELERON PHARMA INCM Exercise/Conversion | +$482K |
| 2019-06-26 | ACCELERON PHARMA INCOption to Purchase Common StockM Exercise/Conversion | — |
| 2019-06-26 | ACCELERON PHARMA INCOption to Purchase Common StockM Exercise/Conversion | — |
| 2019-06-26 | ACCELERON PHARMA INCJ Other | — |
| 2019-06-26 | ACCELERON PHARMA INCM Exercise/Conversion | +$280K |
| 2019-06-26 | ACCELERON PHARMA INCM Exercise/Conversion | +$226K |
| 2019-06-26 | ACCELERON PHARMA INCOption to Purchase Common StockM Exercise/Conversion | — |
| 2019-05-30 | Calithera Biosciences, Inc.Stock Option (Right to Buy)A Award | — |
| 2019-01-25 | ACCELERON PHARMA INCOption to Purchase Common StockA Award | — |
| 2019-01-25 | ACCELERON PHARMA INCA Award | — |
| 2018-06-07 | ATXSAstria Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2018-05-31 | Calithera Biosciences, Inc.Stock Option (Right to Buy)A Award | — |
| 2018-03-01 | ACCELERON PHARMA INCOption to Purchase Common StockA Award | — |
| 2018-03-01 | ACCELERON PHARMA INCA Award | — |
| 2017-12-15 | ACCELERON PHARMA INCS Sale | −$3.76M |
| 2017-07-27 | ATXSAstria Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2017-06-09 | Calithera Biosciences, Inc.Stock Option (Right to Buy)A Award | — |
| 2017-03-02 | ACCELERON PHARMA INCA Award | — |
| 2017-03-02 | ACCELERON PHARMA INCOption to Purchase Common StockA Award | — |
| 2016-12-07 | ACCELERON PHARMA INCWarrants to Purchase Common StockM Exercise/Conversion | — |
| 2016-12-07 | ACCELERON PHARMA INCF Tax Payment | −$748K |
| 2016-12-07 | ACCELERON PHARMA INCM Exercise/Conversion | +$747K |
| 2016-11-17 | ACCELERON PHARMA INCS Sale | −$14.4M |
| 2016-11-17 | ACCELERON PHARMA INCS Sale | −$1.61M |
| 2016-11-16 | ACCELERON PHARMA INCS Sale | −$1.36M |
| 2016-09-30 | ACCELERON PHARMA INCS Sale | −$30.4M |
| 2016-08-03 | ATXSAstria Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2016-06-14 | Calithera Biosciences, Inc.Stock Option (Right to Buy)A Award | — |
| 2016-03-03 | ACCELERON PHARMA INCOption to Purchase Common StockA Award | — |
| 2015-07-22 | Zeltiq Aesthetics IncA Award | — |
| 2015-06-30 | ATXSAstria Therapeutics, Inc.P Purchase | +$149K |
| 2015-06-30 | ATXSAstria Therapeutics, Inc. · Series A Preferred StockC Conversion | — |
| 2015-06-30 | ATXSAstria Therapeutics, Inc.P Purchase | +$1.86M |
| 2015-06-30 | ATXSAstria Therapeutics, Inc.C Conversion | — |
| 2015-06-30 | ATXSAstria Therapeutics, Inc.P Purchase | +$1.09M |
| 2015-06-30 | ATXSAstria Therapeutics, Inc. · Series B Preferred StockC Conversion | — |
Recent filings
- 4George Jean0001209191-24-003437SEC(opens sec.gov)
- 4George Jean0001209191-23-007543SEC(opens sec.gov)
- 4George Jean0000899243-22-007645SEC(opens sec.gov)
- 4George Jean0000899243-21-025821SEC(opens sec.gov)
- 4George Jean0000899243-21-023533SEC(opens sec.gov)
- 4George Jean0000899243-20-016151SEC(opens sec.gov)
- 4George Jean0001179110-20-000775SEC(opens sec.gov)
- 4George Jean0001209191-19-039550SEC(opens sec.gov)
Companies
- ACCELERON PHARMA INCDirector
- ALX ONCOLOGY HOLDINGS INC10% OwnerALXO
- Astria Therapeutics, Inc.DirectorATXS
- Calithera Biosciences, Inc.Director
- CORNERSTONE THERAPEUTICS INCDirector
- Cyteir Therapeutics, Inc.Director
- Disc Medicine, Inc.Director, 10% OwnerIRON
- PORTOLA PHARMACEUTICALS INCDirector
- SHOULDER INNOVATIONS, INC.Former 10% OwnerSI
- Zeltiq Aesthetics IncDirector
Address
BAY COLONY CORPORATE CENTER 1000 WINTER STREET
WALTHAM, MA, 02451